Glenmark launches generic Epinephrine injection in the US, eligible for 180 days of competitive generic therapy exclusivity.

Glenmark Pharmaceuticals launches generic Epinephrine injection in the US, eligible for 180 days of CGT exclusivity. The ...

Mahwah: Glenmark Pharmaceuticals Inc., USA has announced the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Epinephrine injection is used for emergency treatment of severe allergic reactions (including anaphylaxis) to insect bites or ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial. Glenmark's Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Glenmark Pharmaceuticals has launched a generic version of Epinephrine injection multiple-dose vial in the US, gaining 180 days of CGT exclusivity. The injection treats hypotension from septic shock ...

Glenmark Pharmaceuticals Ltd. on Thursday said it has launched the generic version of Epinephrine injection multiple-dose vial in the US, which is eligible for 180 days of competitive generic therapy ...

Glenmark Pharma announced that its US-based subsidiary, Glenmark Pharmaceuticals Inc, has launched the Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial.

Glenmark Pharma launches epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial: Our Bureau, Mumbai Thursday, February 27, 2025, 12:30 Hrs [IST] Glenmark Pharmaceutic ...